Effects of glutamate on exercise tolerance and circulating substrate levels in stable angina pectoris.
The effects of glutamate on exercise tolerance, ischemic threshold and venous substrate concentrations were studied in 20 patients with stable angina pectoris and positive stress tests. Each patient underwent 4 upright bicycle exercise tests on consecutive days. The first and fourth tests were performed without medication while the second and third tests were preceded by a low and high bolus dose of monosodium glutamate, either 0.8 and 1.5 mg/kg body weight intravenously (10 patients) or 40 and 80 mg/kg orally (10 patients). Comparison of the first and fourth tests revealed good reproducibility of electrocardiographic, hemodynamic and metabolic data. Glutamate increased exercise duration (p less than 0.05) in a dose-related way when given intravenously (59 +/- 14 and 153 +/- 14 seconds) and when given orally (53 +/- 21 and 90 +/- 23 seconds; all data are mean +/- standard error of the mean). It also delayed the onset of ST-segment depression (p less than 0.05) by 73 +/- 19, 120 +/- 23, 62 +/- 27 and 80 +/- 30 seconds, respectively. Hemodynamics were not changed by glutamate at rest or at comparable workloads, but at onset of ST-segment depression the heart rate-blood pressure product was increased (p less than 0.05). Glutamate administration induced dose-related 1.5- to 10-fold elevations in plasma glutamate, 15 to 50% decreases in plasma free fatty acids (p less than 0.05) and 5 to 30% increases in plasma alanine contents. Circulating levels of glucose, lactate, citrate and albumin were not modified by glutamate.(ABSTRACT TRUNCATED AT 250 WORDS)
Thomassen
A
A
Department of Cardiology, Skejby Sygehus, Aarhus, Denmark.
Bøtker
H E
HE
Nielsen
T T
TT
Thygesen
K
K
Henningsen
P
P
D000409:Alanine / Q000097:blood; D000787:Angina Pectoris / Q000097:blood / Q000503:physiopathology*; D001774:Blood Chemical Analysis; D002951:Citrates / Q000097:blood; D019343:Citric Acid; D004562:Electrocardiography; D005080:Exercise Test; D005260:Female; D005971:Glutamates / Q000494:pharmacology*; D018698:Glutamic Acid; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007773:Lactates / Q000097:blood; D019344:Lactic Acid; D008297:Male; D008875:Middle Aged; D010807:Physical Endurance / Q000187:drug effects*; D012146:Rest; D013997:Time Factors
D002951:Citrates; D005971:Glutamates; D007773:Lactates; D019343:Citric Acid; D019344:Lactic Acid; D018698:Glutamic Acid; D000409:Alanine